Safety, Tolerability, and Pharmacokinetics of Nebulized GB05-Human IFNα1b Inhalation Solution: A Randomized, Placebo-Controlled, Dose-Escalation Phase I Study in Healthy Chinese Adult Volunteers.
Hengxin PengWenjun ZhangYanqing LinHuiming LiSuofu QinPublished in: Infectious diseases and therapy (2024)
ClinicalTrials.gov Identifier NCT06277167.